awmsg logo



ketoconazole (Ketoconazole HRA®)


Reference No. 2743

Publication date:
30/06/2015


Appraisal information

ketoconazole (Ketoconazole HRA®) 200 mg tablet


Company: HRA Pharma UK & Ireland Ltd
BNF category: Endocrine system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 26/06/2015

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, Ketoconazole (Ketoconazole HRA®) cannot be endorsed for use within NHS Wales for the treatment of endogenous Cushing's syndrome in adults and adolescents above the age of 12 years.
Statement of Advice (SOA)
Download